| pubmed-article:2065312 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2065312 | lifeskim:mentions | umls-concept:C1551338 | lld:lifeskim |
| pubmed-article:2065312 | lifeskim:mentions | umls-concept:C0023473 | lld:lifeskim |
| pubmed-article:2065312 | lifeskim:mentions | umls-concept:C0040028 | lld:lifeskim |
| pubmed-article:2065312 | lifeskim:mentions | umls-concept:C0031526 | lld:lifeskim |
| pubmed-article:2065312 | lifeskim:mentions | umls-concept:C0017287 | lld:lifeskim |
| pubmed-article:2065312 | lifeskim:mentions | umls-concept:C1977882 | lld:lifeskim |
| pubmed-article:2065312 | lifeskim:mentions | umls-concept:C0031525 | lld:lifeskim |
| pubmed-article:2065312 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2065312 | pubmed:dateCreated | 1991-8-13 | lld:pubmed |
| pubmed-article:2065312 | pubmed:abstractText | A 64-year-old woman presented with a platelet count of 3,225 x 10(9)/L. Bone marrow morphology showed massive megakaryocytic hyperplasia; cytogenetic studies showed the presence of the Philadelphia chromosome (Ph). The presence of a rearrangement involving the major breakpoint cluster region (mbcr) on chromosome 22 was confirmed by Southern blotting techniques. A diagnosis of Ph positive essential thrombocythemia (ET) was made. Such cases constitute less than 5% of patients with ET and it has been proposed that they be considered examples of chronic myelogenous leukemia (CML) because of a shared propensity to progress to blast crisis. An argument is presented for retaining Ph positive ET as an entity separate from Ph negative ET and Ph positive CML. | lld:pubmed |
| pubmed-article:2065312 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2065312 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2065312 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2065312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2065312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2065312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2065312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2065312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2065312 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2065312 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:2065312 | pubmed:issn | 0165-4608 | lld:pubmed |
| pubmed-article:2065312 | pubmed:author | pubmed-author:PinkertonP... | lld:pubmed |
| pubmed-article:2065312 | pubmed:author | pubmed-author:SheridanB LBL | lld:pubmed |
| pubmed-article:2065312 | pubmed:author | pubmed-author:LeBrunD PDP | lld:pubmed |
| pubmed-article:2065312 | pubmed:author | pubmed-author:GASSC LCL | lld:pubmed |
| pubmed-article:2065312 | pubmed:author | pubmed-author:Chen-LaiJJ | lld:pubmed |
| pubmed-article:2065312 | pubmed:author | pubmed-author:PoldreP APA | lld:pubmed |
| pubmed-article:2065312 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2065312 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:2065312 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:2065312 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2065312 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2065312 | pubmed:pagination | 21-5 | lld:pubmed |
| pubmed-article:2065312 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:meshHeading | pubmed-meshheading:2065312-... | lld:pubmed |
| pubmed-article:2065312 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:2065312 | pubmed:articleTitle | Essential thrombocythemia with the Philadelphia chromosome and BCR-ABL gene rearrangement. An entity distinct from chronic myeloid leukemia and Philadelphia chromosome-negative essential thrombocythemia. | lld:pubmed |
| pubmed-article:2065312 | pubmed:affiliation | Department of Laboratory Haematology, Sunnybrook Medical Centre, Toronto, Ontario, Canada. | lld:pubmed |
| pubmed-article:2065312 | pubmed:publicationType | Journal Article | lld:pubmed |
